Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone in Acute Schizophrenia
NCT00615433Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Jan 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of lurasidone in schizophrenia, sponsored by Sumitomo Pharma America. Started Jan 2008; status: completed.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00615433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00615433.